An open-label, randomised, single and repeat dose parallel group Phase I study to evaluate the pharmacokinetics of ST10 at three dosage levels in subjects with iron deficiency (with or without anaemia).

Trial Profile

An open-label, randomised, single and repeat dose parallel group Phase I study to evaluate the pharmacokinetics of ST10 at three dosage levels in subjects with iron deficiency (with or without anaemia).

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Ferric maltol (Primary)
  • Indications Iron deficiency anaemia
  • Focus Biomarker; Pharmacokinetics
  • Sponsors Iron Therapeutics
  • Most Recent Events

    • 12 Apr 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
    • 27 Sep 2014 Status changed from recruiting to completed as reported by EudraCT record.
    • 06 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top